Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression.
Axon damage in central nervous system and peripheral nervous system inflammatory demyelinating diseases: common and divergent pathways of dysfunction and tissue damage.
Role of dimethyl fumarate in oxidative stress of multiple sclerosis: A review.
Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms.
[EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN ADULT RATS AFTER ADMINISTRATION OF INTERLEUKIN-1beta DURING DIFFERENT PERIODS OF EARLY LIFE].
Body mass index underestimates adiposity in persons with multiple sclerosis.
Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation.
Oct4 transcription factor in conjunction with valproic acid accelerates myelin repair in demyelinated optic chiasm in mice.
Evaluation of the impact of neutralizing antibodies on IFNβ response.
CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to multiple sclerosis: a meta-analysis.
Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives.
Human polyoma JC virus minor capsid proteins, VP2 and VP3, enhance large T antigen binding to the origin of viral DNA replication: Evidence for their involvement in regulation of the viral DNA replication.
Efficacy of gabapentin in the treatment of SUNCT syndrome.
Masquerades of Acquired Demyelination in Children: Experiences of a National Demyelinating Disease Program.
New evidence for teriflunomide in multiple sclerosis.
[Argyrophil fibrils in the foci of multiple sclerosis; tissue in the central nervous parenchyma].
High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory-thrombotic processes.
Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
Patient experience and practice trends in multiple sclerosis - clinical utility of fingolimod.
Fatigue in Multiple Sclerosis Compared to Stroke.
Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica.
Leukocyte Gene Expression and Plasma Concentration in Multiple Sclerosis: Alteration of Transforming Growth Factor-βs, Claudin-11, and Matrix Metalloproteinase-2.
Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis.
The Elderly Person With Multiple Sclerosis: Clinical Implications for the Increasing Lifespan.
Advances in the management of MS symptoms: recently proposed clinical management algorithms.

Pages